학술논문

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Document Type
Article
Source
In: Investigational New Drugs. (Investigational New Drugs, February 2011, 29(1):161-166)
Subject
Language
English
ISSN
01676997